KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $50.9 million.

  • Fulgent Genetics' Operating Expenses rose 1599.09% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $201.1 million, marking a year-over-year decrease of 3501.27%. This contributed to the annual value of $181.1 million for FY2024, which is 3961.93% down from last year.
  • Per Fulgent Genetics' latest filing, its Operating Expenses stood at $50.9 million for Q3 2025, which was up 1599.09% from $54.1 million recorded in Q2 2025.
  • Fulgent Genetics' Operating Expenses' 5-year high stood at $176.4 million during Q4 2023, with a 5-year trough of $18.4 million in Q1 2021.
  • Moreover, its 5-year median value for Operating Expenses was $43.9 million (2024), whereas its average is $48.6 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 25598.22% in 2023, then tumbled by 7279.05% in 2024.
  • Quarter analysis of 5 years shows Fulgent Genetics' Operating Expenses stood at $38.7 million in 2021, then grew by 28.08% to $49.5 million in 2022, then surged by 255.98% to $176.4 million in 2023, then plummeted by 72.79% to $48.0 million in 2024, then grew by 6.0% to $50.9 million in 2025.
  • Its Operating Expenses stands at $50.9 million for Q3 2025, versus $54.1 million for Q2 2025 and $48.1 million for Q1 2025.